The molecular mechanism, diagnosis and treatment of FGFR2 mutation in intrahepatic cholangiocarcinoma

doi:10.3781/j.issn.1000-7431.2023.2302-0088

PDF(2545 KB)

Tumor ›› 2023, Vol. 43 ›› Issue (07) : 598-606. DOI: 10.3781/j.issn.1000-7431.2023.2302-0088

Review

The molecular mechanism, diagnosis and treatment of FGFR2 mutation in intrahepatic cholangiocarcinoma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 43(07): 598-606 https://doi.org/10.3781/j.issn.1000-7431.2023.2302-0088

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2545 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2023-03-01	2023-05-08	2023-07-25
Issue Date
2023-07-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS